Zdrowie i gospodarka · 17.06.2010
Oversight of Laboratory Developed Tests; Public Meeting; Request for Comments
The Food and Drug Administration (FDA) is announcing the following public meeting: "Oversight of Laboratory Developed Tests." The purpose of the public meeting is to create a forum for interested stakeholders to discuss the agency's oversight of laboratory developed tests (LDTs). FDA is seeking input and requesting comments on this topic. Date and Time: The public meeting will be held on July 19 and 20, 2010, from 8 a.m. to 5 p.m. Location: The public meeting will be held at Crowne Plaza Washington, DC - Rockville, 3 Research Court, Rockville, MD 20850. For directions, please contact the hotel 301-840-0200 or refer to the meeting web page at http://www.fda.gov/MedicalDevices/NewsEvents/ WorkshopsConferences/default.htm. Contact: Katherine Serrano, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 66, rm. 5613, Silver Spring MD 20993-0002, 301-796-6652, e-mail: [email protected]. Registration and Requests for Oral Presentations: There is no registration fee to attend the public meeting. Registration can be completed online at http://www.fda.gov/MedicalDevices/NewsEvents/ WorkshopsConferences/default.htm. Online regi